Wealthcreatures.com
описание
Visit us at www.wealthcreatures.com Driven by Fundamentals and Leveraging Technicals. All post are Only For Study & Educational Purpose.consult you Financial Advisor Before Investing or taking any position. DISCLAIMER:We r Not SEBI REGISTERED ANALYST.
1 357
подписчиков
Охват к подписчикам
40,6%
ERR
Реакции к просмотрам
0,43%
69 на 28 постов
Пересылки к просмотрам
0,04%
6
Постов в день
1,6
всего 28
Где отзываются чаще
доля реакций к просмотрам- 13 авг.Every stock gives opportunity on either side to enter and to exit. When the stock is looking cheap to enter, you think it may go further down and you will enter at better price. You don't have courage to take risk. When the stock is looking good to exit, you think it may go more up and you will exit at better price. You don't have courage to move on. More than stock picking, what matters is ~ courage ~ entry ~ allocation ~ patience ~ discipline ~ exit And ~ conviction to HOLD If it is not tough to make money, it is not easy too. If Making money becomes too easy, Losing money is gonna be much easier. THINK ABOUT IT Study 📚 & Train your brain 🧠 and mindset which would help1,84%
- 13 авг.Mindset To Earn Money vs Making Wealth If you wish to make money then makes sense to be excited about 20-30% moves wealth start getting excited about finding the companies which can be 2-5-10x1,64%
- 11 авг.#Wockhardt pharma is the only company in India which owns 6 QIDP drugs approved by USFDA One QIDP drug has a market size of 450cr-1000cr in US with an additional exclusivity of 5 yrs Global market size of QIDP is around as of now $115 Billion💰1,20%
- 16 авг.без подписи0,99%
- 17 авг.TRIPLE-DIGIT GROWTH CLUB: Q1 FY27’S BIGGEST WINNERS KRN Heat Exchanger Sales growth: 120% Profit growth: 104%0,94%
- 17 авг.TRIPLE-DIGIT GROWTH CLUB: Q1 FY27’S BIGGEST WINNERS E2E Networks Sales growth: 333% Profit growth: 193%0,89%
- 16 авг.Dolat Algo FY27 Q1 Revenue 140.40 Cr vs 110.60 Cr (+26.94% YoY┃+11.52% QoQ) EBITDA 84.25 Cr vs 64.99 Cr (+29.63% YoY ┃+10.31% QoQ) EBITDA Margin 60.01% vs 58.76% YoY & 60.67% QoQ PBT 73.25 Cr vs 54.85 Cr (+33.54% YoY┃+13.52% QoQ) PAT 53.86 Cr vs 38.93 Cr (+38.36% YoY┃+15.06% QoQ) PAT After Minority interest 53.82 Cr vs 38.81 Cr (+38.68% YoY┃+15.20% QoQ) Other Income 0.45 Cr vs 0.68 Cr YoY & 0.03 Cr QoQ0,76%
- 17 авг.TRIPLE-DIGIT GROWTH CLUB: Q1 FY27’S BIGGEST WINNERS Netweb Sales growth: 172% Profit growth: 96%0,61%
- 13 авг.Azad Engineering 5% 💚 2599 Fresh ATH0,53%
- 4 авг.3 big boys Stock Shld do well in coming 12-18-24-36 -42 months BSE LTD Shriram Piston Waaree Energies0,50%
- 10 авг.Wockhardt Pharma FY27 Q1 ✅ Revenue: ₹929 Cr (+25.9% YoY) ✅ PBT: ₹116 Cr (vs Loss of ₹12 Cr YoY) ✅ PAT: ₹107 Cr (vs Loss of ₹108 Cr YoY) ✅ EPS: ₹6.55 (vs -₹5.53 YoY) Wockhardt delivered a strong turnaround in Q1 FY27, with revenue growing 26% YoY and the company moving from losses to healthy profitability. Improved operating performance and better cost management supported the sharp recovery in PBT and PAT.0,49%
- 4 авг.Shriram piston Decent Numbers Revenue 1474.40 Cr vs 963.30 Cr (+53.06% YoY┃+1.28% QoQ) EBITDA 258.00 Cr vs 195.10 Cr (+32.24% YoY ┃-3.70% QoQ) EBITDA Margin 17.50% vs 20.25% YoY & 18.40% QoQ PBT Ex-Exceptional Items 195.20 Cr vs 183.00 Cr (+6.67% YoY┃-6.24% QoQ) PAT 147.70 Cr vs 134.90 Cr (+9.49% YoY┃-7.17% QoQ) PAT After Minority interest 144.40 Cr vs 133.70 Cr (+8.00% YoY┃-7.61% QoQ) Other Income 24.80 Cr vs 28.40 Cr YoY & 24.90 Cr QoQ Last Q4 Exceptional loss of 1.9 Cr0,48%